Stockscreener 앱 받기
4.41
2.43%
-0.11
시간 외 거래:
4.41
전일 마감가:
$4.52
열려 있는:
$4.43
하루 거래량:
412.79K
Relative Volume:
0.65
시가총액:
$207.01M
수익:
$138.90M
순이익/손실:
$-107.15M
주가수익비율:
-1.7478
EPS:
-2.5232
순현금흐름:
$-79.85M
1주 성능:
-7.35%
1개월 성능:
-25.88%
6개월 성능:
-18.78%
1년 성능:
-38.75%
1일 변동 폭
$4.355
$4.555
1주일 범위
$4.355
$4.926
52주 변동 폭
$4.05
$8.77
Quanterix Corp Stock (QTRX) Company Profile
명칭
Quanterix Corp
전화
617-301-9400
주소
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
4.41 | 212.17M | 138.90M | -107.15M | -79.85M | -2.5232 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-11 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-02-01 | 개시 | Scotiabank | Sector Outperform |
| 2023-09-25 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-08-08 | 업그레이드 | SVB Securities | Market Perform → Outperform |
| 2023-05-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-08-15 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-08-09 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-08-09 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-03-02 | 업그레이드 | Goldman | Sell → Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-04 | 개시 | Goldman | Sell |
모두보기
Quanterix Corp 주식(QTRX)의 최신 뉴스
Invenomic Capital Management LP Grows Stake in Quanterix Corporation $QTRX - MarketBeat
Risk Report: Whats the MACD signal for Quanterix CorporationRate Cut & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Quanterix rises on CMS price for LucentAD Alzheimer blood biomarker test - MSN
Quanterix at Leerink Global Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Quanterix at Leerink Global Healthcare Conference: Strategic Growth Insights - Investing.com
Quanterix at TD Cowen Conference: Strategic Growth and Diagnostics Focus - Investing.com
William Blair Investment Management LLC Increases Holdings in Quanterix Corporation $QTRX - MarketBeat
Quanterix Corporation (NASDAQ:QTRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Quanterix Q4 Earnings Call Highlights - Defense World
Quanterix (QTRX) Revenue Growth Keeps Losses Central To Bulls’ Long-Term Narrative - simplywall.st
Quanterix (QTRX) Q4 2025 Earnings Call Transcript - AOL.com
Quanterix Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss - Investing.com Australia
Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss By Investing.com - Investing.com South Africa
Quanterix Corp (QTRX) Q4 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic Shifts - GuruFocus
Quanterix Q4 2025 Earnings Call Transcript - MarketBeat
Quanterix Q4 2025 slides: cost cuts drive path to cash flow breakeven - Investing.com South Africa
Quanterix Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Quanterix earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Quanterix (QTRX) Releases Revenue and Margin Projections for 202 - GuruFocus
Quanterix Corporation (QTRX) Releases Q4 2025 Earnings: Revenue Beats but EPS Slightly Misses - Quiver Quantitative
Quanterix (NASDAQ:QTRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat
Quanterix Corporation 8-K Filing Analysis - TradingView
Quanterix (QTRX) grows Q4 revenue, deepens 2025 loss, eyes 2026 cash breakeven - Stock Titan
Quanterix Earnings Report: Q4 Overview - Benzinga
Alzheimer’s blood test heads to 15,000 community events a year - Stock Titan
Quanterix (QTRX) Set to Announce Q4 Earnings with Revenue Growth Expected - GuruFocus
Quanterix (QTRX) to Release Earnings on Monday - Defense World
Quanterix Corp expected to post a loss of 45 cents a shareEarnings Preview - TradingView
Earnings Outlook For Quanterix - Benzinga
Quanterix Corp (QTRX) Q4 2025 Earnings Report Preview: What To L - GuruFocus
Quanterix to Participate in Upcoming Investor Conferences - ChartMill
Envestnet Asset Management Inc. Grows Holdings in Quanterix Corporation $QTRX - Defense World
QTRX Should I Buy - Intellectia AI
Quanterix (QTRX) Expected to Announce Quarterly Earnings on Monday - MarketBeat
Investors can hear Quanterix 2025 results discussed on Mar. 2 call - Stock Titan
Quanterix (NASDAQ:QTRX) Shares Up 0.7%Time to Buy? - MarketBeat
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer’s Blood Test - Clinical Lab Products
With 68% ownership, Quanterix Corporation (NASDAQ:QTRX) boasts of strong institutional backing - Yahoo Finance
Quanterix submits FDA 510(k) for multi-analyte Alzheimer's blood test - MSN
Aug Swings: Should value investors consider Quanterix CorporationGlobal Markets & Growth Focused Entry Point Reports - baoquankhu1.vn
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test - TradingView
Quanterix (QTRX) Submits Alzheimer's Blood Test for FDA Approval - GuruFocus
Quanterix submits FDA 510(k) for multi-analyte Alzheimer’s blood test - Investing.com
Blood test to spot Alzheimer’s earlier moves to FDA review - Stock Titan
What’s the MACD signal for Quanterix CorporationWeekly Volume Report & Long-Term Growth Stock Strategies - mfd.ru
Quanterix (NASDAQ:QTRX) Trading Down 3.6%Here's What Happened - MarketBeat
Quanterix (NASDAQ:QTRX) Trading Down 3.6% – Here’s What Happened - Defense World
Former Illumina Executive Moves Into Quanterix’s Corner Office - Medical Product Outsourcing
Study finds multi-biomarker approach improves Alzheimer’s risk assessment - Investing.com
Quanterix Corp (QTRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):